| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 136.81B | 138.18B | 137.91B | 139.49B | 127.64B | 107.00B |
| Gross Profit | 38.50B | 38.63B | 37.84B | 35.36B | 35.07B | 26.67B |
| EBITDA | 21.67B | 22.45B | 20.22B | 17.39B | 16.23B | 8.92B |
| Net Income | 12.16B | 12.94B | 11.48B | 10.02B | 9.07B | 2.81B |
Balance Sheet | ||||||
| Total Assets | 200.70B | 198.31B | 202.07B | 180.59B | 163.56B | 154.91B |
| Cash, Cash Equivalents and Short-Term Investments | 16.14B | 16.61B | 21.34B | 14.60B | 14.17B | 12.26B |
| Total Debt | 21.49B | 6.09B | 2.72B | 12.62B | 6.59B | 8.00B |
| Total Liabilities | 49.80B | 47.45B | 54.10B | 51.62B | 44.76B | 40.92B |
| Stockholders Equity | 150.01B | 149.98B | 147.10B | 128.19B | 118.12B | 110.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.79B | 16.72B | -5.57B | 8.01B | -527.00M |
| Operating Cash Flow | 0.00 | 2.02B | 22.04B | -213.00M | 12.84B | 5.90B |
| Investing Cash Flow | 0.00 | -5.26B | -3.24B | -3.52B | -5.82B | -7.60B |
| Financing Cash Flow | 0.00 | -3.03B | -13.49B | 3.31B | -5.39B | 1.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥196.36B | 16.00 | 8.27% | 2.68% | -2.45% | 7.31% | |
78 Outperform | ¥583.93B | 18.64 | 13.63% | 1.95% | -1.33% | 9.21% | |
75 Outperform | ¥159.97B | 13.29 | ― | 2.66% | -1.63% | 67.13% | |
72 Outperform | ¥4.49B | 9.99 | ― | 2.79% | 3.32% | 18.84% | |
71 Outperform | ¥1.21T | 20.25 | 8.51% | 3.13% | 1.90% | -6.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥326.46B | -3.99 | -20.43% | 3.72% | -8.20% | ― |
Noritake Co., Limited reported consolidated net sales of ¥104.19 billion for the nine months ended December 31, 2025, down 0.8% year on year, with operating profit slipping 3.1% to ¥7.86 billion and profit attributable to owners of parent declining 5.6% to ¥8.68 billion. Despite softer earnings, total assets rose to ¥224.74 billion and equity increased to ¥159.66 billion, lifting comprehensive income sharply and underscoring a strengthened balance sheet.
The company maintained its full-year forecast for fiscal 2026, projecting modest growth in net sales to ¥141 billion and higher operating and ordinary profit, even as full-year profit attributable to owners of parent is expected to fall 7.3% to ¥12 billion. Noritake also kept its dividend outlook unchanged, targeting a total annual dividend of ¥160 per share, signaling continued shareholder returns amid a stable yet slightly pressured earnings environment.
The most recent analyst rating on (JP:5331) stock is a Buy with a Yen7270.00 price target. To see the full list of analyst forecasts on Noritake Co.,Limited stock, see the JP:5331 Stock Forecast page.
Noritake Co., Limited has approved a 2-for-1 stock split of its common shares, effective April 1, 2026, in a move aimed at lowering the per-share investment price, improving stock liquidity, and broadening its investor base. In conjunction with the split, the company will amend its Articles of Incorporation to double the total number of authorized shares from 79.5 million to 159 million, while confirming that year-end dividends for the fiscal year ending March 31, 2026, will be calculated on the pre-split share count and that the existing shareholder benefit program will remain unchanged, effectively expanding its reach post-split for eligible investors.
The most recent analyst rating on (JP:5331) stock is a Buy with a Yen6122.00 price target. To see the full list of analyst forecasts on Noritake Co.,Limited stock, see the JP:5331 Stock Forecast page.